Source: Annual Congress 2008 - Prognosis in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. R. De Carlo, M. Moretti, L. M. Fabbri (Modena, Italy). The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients. Eur Respir J 2008; 32: Suppl. 52, 536

Member's Comments

No comment yet.

Related content which might interest you: GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 The discriminatory capacity of the GOLD classification for health status outcomes in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 728s Year: 2006 Impact of comorbidities on survival of patients with COPD according to GOLD stages Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Psychologic impairment according to GOLD COPD staging for patients in a primary care setting Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007 Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Comparison of functionality and symptoms in COPD patients with different nutritional status Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016 COPD GOLD classification in patients with COPD-OSA overlap syndrome Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020 COPD staging systems and BODE index Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 GOLD stage in COPD not predictive of health status outcomes before and after pulmonary rehabilitation Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease Year: 2010 Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Impact of co-morbidities on the rehabilitation outcome in COPD patients Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 The relationship between depression, medication and stage of the disease in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Distribution of COPD patients in the GOLD assessment framework by exacerbations Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Glycopyrronium significantly improves lung function, dyspnea and health status in COPD patients in all GOLD groups Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging systems: a pooled analysis of individual patient data Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005 Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Ergoreflex and the method of assessing the functional status in patients with COPD Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018